Rose became acquainted with Patient Worthy after her husband was diagnosed with Acute Myeloid Leukemia (AML) six years ago. During this period of partial remission, Rose researched investigational drugs to be prepared in the event of a relapse. Her husband died February 12, 2021 with a rare and unexplained occurrence of liver cancer possibly unrelated to AML.
445 words 10% matched vs. 2061 words 2% matched We invented medicines to kill bacteria; now, the bacteria are killing us. Lucien Swetschinski, a researcher and co-author at IHME, told…
Continue Reading
Experts Are Comparing the Threat of Bacterial Antimicrobial Resistance (AMR) to the HIV/AIDS Health Crisis
source: pixabay.com
Josie Lawrence, a 42-year-old comedian and actress residing in East London, UK, has adopted an unconventional training routine for her even more extraordinary walk along the Great Chinese Wall,…
Continue Reading
Comedian and Actress Trained for Charity Walk after Deep Cartilage Knee Damage
Editor's Note: We believe that patients are a key part of developing and leading the conversation in disease communities. Patient Worthy sometimes partners with reputable agencies that wish to speak…
Continue Reading
Study: The Effect of Patient Support Groups on Pulmonary Hypertension Patients and their Caregivers
source: pixabay.com
The goal of providing precision techniques to cancer care is becoming increasingly complicated. According to a recent article in Inside Precision Medicine, the cause may be attributed to the…
Continue Reading
Using AI Software to Support Clinical Decisions in Cancer Treatment
source: pixabay.com
The FDA has granted IDEAYA Biosciences fast track status for IDE161 as a treatment for HR+, Her2- breast cancer. The therapy is a selective inhibitor of ADP ribose glycohydrolase…
Continue Reading
IDEAYA’s IDE161 Receives Fast Track Designation for HR+ Her2- Breast Cancer
source: pixabay.com
The need for increased awareness about Alzheimer’s disease is growing. The number of Alzheimer’s patients has increased since 1983, the year President Reagan designated November as Alzheimer’s Disease Awareness…
Continue Reading
November was Alzheimer’s Awareness Month
source: shutterstock.com
CRISPR was first described ten years ago as a viral mechanism for defense, taken from bacteria, which could be transformed into genetic scissors and accurately alter DNA. About Casgevy CRISPR…
Continue Reading
U.K. Health Authorities Grant Approval for a New Medicine using CRISPR Gene Editing to Treat Beta thalassemia and Sickle Cell
source: pixabay.com
Patients with severe asthma with an eosinophilic phenotype who are 12 years of age or older may now receive treatment with FASENRA as an add-on maintenance treatment. Note that…
Continue Reading
Phase III Trial meets Primary Endpoint for Patients with Eosinophilic Granulomatosis with Polyangiitis (EGPA)
Source: https://unsplash.com/photos/ZHys6xN7sUE
Vamorolone, now marketed as AGAMREE®, is termed a dissociative steroid therapy, as it has proven its potential to retain the muscle-strengthening and anti-inflammatory benefits of corticosteroids. On the other side…
Continue Reading
Vamorolone Has Been FDA Approved to Treat Duchenne Muscular Dystrophy
source: unsplash.com
In December 2019, three months after his retirement, Paul Goodfellow received a diagnosis of invasive cancer of the bladder. He received three cycles of chemotherapy and then major surgery that…
Continue Reading
Combo Treatment in Clinical Trial Doubles Metastatic Bladder Cancer Survival
In the year 2000, the number of Dengue cases was reported to be approximately one-half million. In October 2023 the total reached 4.2 million cases of Dengue virus. The virus…
Continue Reading
As Temperatures Rise, Dengue Fever is Spreading. Can it be Stopped?
source: shutterstock.com
Every three to four minutes, someone in the U.S. is diagnosed with a blood disease such as lymphoma, leukemia, or sickle cell anemia. As reported in the Pittsburgh Post-Gazette,…
Continue Reading
Mom Signed Up Thousands of Stem Cell Donors in Support of Son with IPEX
The words ‘vigorous exercise’ usually bring to mind running marathons or playing pickleball. Inside Precision Medicine reports that researchers at a Sydney, Australia University tracked the daily activity of more…
Continue Reading
Study Shows an Average of 4 1/2 Minutes of Vigorous Exercise May Reduce the Risk of Cancer by 32%
Chip Wilson, billionaire founder of Lululemon Athletica, was first diagnosed with muscular dystrophy in 1987 at the age of 32. Wilson, who is now 66 years old told Global…
Continue Reading
Wealthy Facioscapulohumeral Muscular Dystrophy Patient Invests $100 Million to Find a Cure
source: pixabay.com
Arcus Biosciences and Gilead Sciences issued a press release announcing encouraging overall response rates and six-month progression-free survival rate for their combination treatment of domvanalimab plus zimberelimab and chemotherapy…
Continue Reading
Encouraging Findings in Phase 2 Gastric Cancer Clinical Trial
source: pixabay.com
Cancer immunotherapy has transformed the landscape of cancer treatment, revealing that not all patients with solid tumors respond effectively to this approach. As reported by News Medical Life Sciences,…
Continue Reading
Nanocapsules Enhance Immune Response Against Cancer Tumors
source: pixabay.com
An individual has a good chance of recovering from an injury to his or her legs or arms, but it is not always the case when the injury involves…
Continue Reading
Scientists Find Biomarker for Predicting Neuron Repair, with Implications for Future Therapies
source: pixabay.com
Scientists have previously suggested that the gut microbiome plays a role in causing Alzheimer’s disease, and this has now been confirmed. A recent report from ScienceAlert covered a study…
Continue Reading
Scientists Demonstrate Gut Microbiome Connection with Transfer of Alzheimer’s to Healthy Animals
source: shutterstock.com
Professionals from all corners of the world convene at SSIEM each year to discuss the latest groundbreaking discoveries. According to a report in BioSpace, one such breakthrough was presented by…
Continue Reading
Promising Interim Data in Phase 1/2 Hunter Syndrome Trial
source: shutterstock.com
If Wave Life Sciences’ recently submitted trial application for WVE-006 is approved, it will become the first RNA editing treatment in a clinical development setting. Wave’s CEO, Paul Bolno,…
Continue Reading
Wave Life Science’s New Trial Application is Causing Renewed Excitement Around RNA Editing
source: shutterstock.com
Imagine the frustration of Faustina Cavero, unable to follow her maternal instincts that told her something was wrong with her baby. Doctors at two different hospitals disagreed with her and…
Continue Reading
Infantile Spasms: Mom Saves Baby’s Life After Being Dismissed by Two Hospitals
source: shutterstock.com
Editor's Note: We believe that patients are a key part of developing and leading the conversation in disease communities. Patient Worthy sometimes partners with reputable agencies that wish to speak…
Continue Reading
Analysis: Reasons for Small Cell Lung Cancer Patients Refusing Treatment
source: pixabay.com
The xenotransplant involved transplanting Yucatan miniature pig kidneys into macaque monkeys with 69 genetic modifications. One monkey survived for over two years, offering hope to the team of Harvard…
Continue Reading
Scientists Are Calling Monkey’s Two-Year Survival After a Pig Kidney Transplant “Unprecedented”
Editor's Note: We believe that patients are a key part of developing and leading the conversation in disease communities. Patient Worthy sometimes partners with reputable agencies that wish to speak…
Continue Reading
The History of Post-Traumatic Stress Disorder
Editor's Note: We believe that patients are a key part of developing and leading the conversation in disease communities. Patient Worthy sometimes partners with reputable agencies that wish to speak…
Continue Reading
Researchers Seek Reason for a Higher Survival Rate in Obese Patients with Pulmonary Arterial Hypertension (PAH)